|
protection from non homologous end joining at telomere
|
GO:0031848 |
4 |
0.988
|
Mouse |
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.104
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.096
|
Mouse |
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.096
|
|
|
methylation
|
GO:0032259 |
134 |
0.095
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.093
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.092
|
|
|
telomere maintenance
|
GO:0000723 |
19 |
0.071
|
Mouse |
|
chromatin modification
|
GO:0016568 |
187 |
0.068
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.067
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.064
|
Mouse |
|
microtubule polymerization or depolymerization
|
GO:0031109 |
26 |
0.064
|
|
|
regulation of microtubule polymerization or depolymerization
|
GO:0031110 |
20 |
0.063
|
|
|
histone modification
|
GO:0016570 |
159 |
0.063
|
|
|
regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032434 |
40 |
0.062
|
|
|
telomere maintenance in response to dna damage
|
GO:0043247 |
4 |
0.062
|
Mouse |
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.061
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.060
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.059
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.059
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.054
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.054
|
|
|
mitotic spindle checkpoint
|
GO:0071174 |
9 |
0.052
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.052
|
|
|
regulation of microtubule based process
|
GO:0032886 |
52 |
0.051
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.050
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.050
|
|
|
regulation of microtubule polymerization
|
GO:0031113 |
7 |
0.048
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.045
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
56 |
0.045
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.045
|
Mouse |
|
protein maturation
|
GO:0051604 |
176 |
0.044
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.043
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.043
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.043
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.042
|
|
|
negative regulation of dna replication
|
GO:0008156 |
4 |
0.041
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.041
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.041
|
|
|
telomere capping
|
GO:0016233 |
4 |
0.041
|
Mouse |
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.040
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.040
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.040
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.040
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.039
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.039
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.039
|
|
|
regionalization
|
GO:0003002 |
337 |
0.039
|
|
|
telomere maintenance via telomerase
|
GO:0007004 |
1 |
0.039
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.039
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.039
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.038
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.038
|
|
|
dna biosynthetic process
|
GO:0071897 |
22 |
0.038
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.037
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.037
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.037
|
|
|
rna dependent dna replication
|
GO:0006278 |
3 |
0.037
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.036
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.036
|
|
|
dna replication
|
GO:0006260 |
52 |
0.036
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.036
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.036
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.035
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.035
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.034
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.033
|
|
|
vacuole organization
|
GO:0007033 |
38 |
0.033
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.033
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.033
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.033
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.032
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
47 |
0.032
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.032
|
|
|
protein processing
|
GO:0016485 |
163 |
0.032
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.032
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.031
|
|
|
microtubule polymerization
|
GO:0046785 |
12 |
0.031
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.031
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.031
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.030
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.029
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.029
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.029
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.028
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.028
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.028
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.028
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.028
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.028
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
46 |
0.028
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.028
|
|
|
negative regulation of chromosome organization
|
GO:2001251 |
30 |
0.027
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.027
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.027
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.027
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.027
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.027
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.027
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.027
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.027
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.026
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.026
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.026
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.026
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
33 |
0.026
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.026
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.026
|
|
|
protein homooligomerization
|
GO:0051260 |
43 |
0.026
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.026
|
|
|
cell division
|
GO:0051301 |
120 |
0.026
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.025
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.025
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.025
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.025
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.025
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.025
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.025
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.025
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.025
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.025
|
|
|
negative regulation of nuclear division
|
GO:0051784 |
19 |
0.025
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.024
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.024
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.024
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.024
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.024
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.024
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.023
|
|
|
positive regulation of microtubule polymerization or depolymerization
|
GO:0031112 |
3 |
0.023
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.023
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.023
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.023
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.023
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.023
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.023
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.022
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.022
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.022
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.022
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
45 |
0.022
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.022
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.022
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.022
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.022
|
|
|
chromosome separation
|
GO:0051304 |
14 |
0.022
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.022
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.021
|
|
|
mitotic nuclear division
|
GO:0007067 |
48 |
0.021
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.021
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.021
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.021
|
|
|
negative regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903051 |
22 |
0.021
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.021
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.021
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.021
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.020
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
31 |
0.020
|
|
|
gland development
|
GO:0048732 |
330 |
0.020
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.020
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.020
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.020
|
|
|
negative regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032435 |
15 |
0.020
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.020
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.020
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.020
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.020
|
|
|
mitotic sister chromatid separation
|
GO:0051306 |
9 |
0.020
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.020
|
|
|
negative regulation of cellular protein catabolic process
|
GO:1903363 |
22 |
0.020
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.019
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.019
|
|
|
cation transport
|
GO:0006812 |
399 |
0.019
|
|
|
positive regulation of microtubule polymerization
|
GO:0031116 |
3 |
0.019
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.019
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.019
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.019
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.018
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.018
|
|
|
cell cycle checkpoint
|
GO:0000075 |
47 |
0.018
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.018
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.018
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.018
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.018
|
|
|
lysosome organization
|
GO:0007040 |
21 |
0.018
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.017
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.017
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.017
|
|
|
sister chromatid segregation
|
GO:0000819 |
20 |
0.017
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.017
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
49 |
0.017
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.017
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.017
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.017
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.016
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.016
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.016
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.016
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.016
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.016
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.016
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.016
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.016
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.016
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.016
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.016
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.016
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.016
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.016
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.016
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.015
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.015
|
|
|
positive regulation of nuclear division
|
GO:0051785 |
27 |
0.015
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.015
|
|
|
appendage development
|
GO:0048736 |
166 |
0.015
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.015
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.015
|
|
|
metaphase anaphase transition of mitotic cell cycle
|
GO:0007091 |
9 |
0.015
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.015
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.015
|
|
|
mitotic sister chromatid segregation
|
GO:0000070 |
14 |
0.015
|
|
|
regulation of dna methylation
|
GO:0044030 |
12 |
0.015
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.015
|
|
|
negative regulation of protein catabolic process
|
GO:0042177 |
36 |
0.015
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.015
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.014
|
|
|
regulation of mitosis
|
GO:0007088 |
29 |
0.014
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.014
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.014
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.014
|
|
|
regulation of telomerase activity
|
GO:0051972 |
1 |
0.014
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.014
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.014
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.014
|
|
|
ear development
|
GO:0043583 |
200 |
0.014
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.014
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.014
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.014
|
|
|
coenzyme a metabolic process
|
GO:0015936 |
8 |
0.014
|
|
|
negative regulation of cell division
|
GO:0051782 |
24 |
0.013
|
|
|
regulation of chromosome segregation
|
GO:0051983 |
21 |
0.013
|
|
|
dna alkylation
|
GO:0006305 |
43 |
0.013
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.013
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.013
|
|
|
ossification
|
GO:0001503 |
216 |
0.013
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.013
|
|
|
renal system development
|
GO:0072001 |
225 |
0.013
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.013
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.013
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.013
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.013
|
|
|
neuron death
|
GO:0070997 |
154 |
0.013
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.013
|
|
|
dna modification
|
GO:0006304 |
50 |
0.013
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.013
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.013
|
|
|
dna catabolic process endonucleolytic
|
GO:0000737 |
15 |
0.013
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.013
|
|
|
regulation of sister chromatid segregation
|
GO:0033045 |
13 |
0.013
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.013
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.013
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.013
|
|
|
dna methylation
|
GO:0006306 |
43 |
0.013
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.012
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.012
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.012
|
|
|
positive regulation of cell division
|
GO:0051781 |
31 |
0.012
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.012
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.012
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.012
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.012
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.012
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.012
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.012
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.012
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.012
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.012
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.012
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.012
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.012
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.012
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.012
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.012
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.012
|
|
|
trna wobble base modification
|
GO:0002097 |
2 |
0.012
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.012
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.012
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.012
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.012
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.012
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.012
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.012
|
|
|
regulation of histone methylation
|
GO:0031060 |
30 |
0.012
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.012
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.012
|
|
|
lung development
|
GO:0030324 |
164 |
0.012
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.012
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.012
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.012
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.012
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.012
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.011
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.011
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.011
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.011
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.011
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.011
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.011
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.011
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.011
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.011
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.011
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.011
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.011
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.011
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.011
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.011
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.011
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.011
|
|
|
wound healing
|
GO:0042060 |
157 |
0.011
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.011
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.011
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.011
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.011
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.011
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.011
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.011
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.011
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.011
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.011
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.011
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.011
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.011
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.011
|
|
|
cellular response to gamma radiation
|
GO:0071480 |
4 |
0.011
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.011
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.011
|
|
|
cilium morphogenesis
|
GO:0060271 |
102 |
0.011
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.011
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.011
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.011
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.011
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.010
|
|
|
spindle checkpoint
|
GO:0031577 |
12 |
0.010
|
|
|
anion transport
|
GO:0006820 |
177 |
0.010
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.010
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.010
|
|
|
cell cycle g2 m phase transition
|
GO:0044839 |
20 |
0.010
|
|
|
anaphase promoting complex dependent proteasomal ubiquitin dependent protein catabolic process
|
GO:0031145 |
9 |
0.010
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.010
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.010
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.010
|
|
|
segmentation
|
GO:0035282 |
93 |
0.010
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.010
|
|
|
regulation of metaphase anaphase transition of cell cycle
|
GO:1902099 |
9 |
0.010
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.010
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.010
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.010
|
|
|
placenta development
|
GO:0001890 |
140 |
0.010
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.010
|
|